[1]
|
H. K. B. Simmerman and L. R. Jones, “Phospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function,” Physiological Reviews, Vol. 78, 1998, pp. 921-947.
|
[2]
|
P. James, M. Inui, M. Tada, M. Chiesi and E. Carafoli, “Nature and Site of Phospholamban Regulation of the Calcium Pump of Sarcoplasmic Reticulum,” Nature, Vol. 342, 1989, pp. 90-92. http://dx.doi.org/10.1038/342090a0
|
[3]
|
M. A. Kirchberger, M. Tada and A. M. Katz, “Phospholamban a Regulatory Protein of the Cardiac Sarcoplasmic Reticulum,” Recent Advances in Studies on Cardiac Structure and Metabolism, Vol. 5, 1975, pp. 103-115.
|
[4]
|
J. Fuji, A. Ueno, K. Kitano, S. Tanaka, M. Kadoma and M. Tada, “Complete Complementary DNA-Derived Amino Acid Sequence of Canine Cardiac Phospholamban,” Journal of Clinical Investigation, Vol. 79, 1987, pp. 301-304. http://dx.doi.org/10.1172/JCI112799
|
[5]
|
Q. Yao, J. L. Bevan, R. F. Weaver and D. J. Bigelow, “Purification of Porcine Phospholamban Expressed in Escherichia coli,” Protein Expression and Purification, Vol. 8, 1996, pp. 463-468. http://dx.doi.org/10.1006/prep.1996.0125
|
[6]
|
J. G. Collins, E. G. Kranias, A. S. Reeves, L. M. Bilezikjian and A. Schwartz, “Isolation of Phospholamban and a Second Proteolipid Component from Canine Cardiac Sarcoplasmic Reticulum,” Biochemical and Biophysical Research Communications, Vol. 99, 1981, pp. 796-803. http://dx.doi.org/10.1016/0006-291X(81)91235-3
|
[7]
|
E. J. Mayer, E. McKenna, V. M. Garsky, C. J. Burke, H. Mach, C. R. Middaugh, M. Sardana, J. S. Smith and R. G. Johnson Jr., “Biochemical and Biophysical Comparison of Native and Chemically Synthesized Phospholamban and a Monomeric Phospholamban,” The Journal of Biological Chemistry, Vol. 271, 1996, pp. 1669-1677. http://dx.doi.org/10.1074/jbc.271.3.1669
|
[8]
|
D. J. Hirsh, J. Hammer, W. L. Maloy, J. Blazyk and J. Schaefer, “Secondary Structure and Location of a Magainin Analogue in Synthetic Phospholipid Bilayers,” Biochemistry, Vol. 35, 1996, pp. 12733-12741. http://dx.doi.org/10.1021/bi961468a
|
[9]
|
A. Mascioni, C. Karim, J. Zamoon, D. D. Thomas and G. Veglia, “Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban,” Journal of the American Chemical Society, Vol. 124, 2002, pp. 9392-9393. http://dx.doi.org/10.1021/ja026507m
|
[10]
|
E. K. Tiburu, P. C. Dave, K. Damodaran and G. A. Lorigan, “Investigating Leucine Side-Chain Dynamics and Backbone Conformations of Phospholamban Incorporated in Phospholipid Bilayers Utilizing 2H and 15N SolidState NMR Spectroscopy,” Biochemistry, Vol. 43, 2004, pp. 13899-13909. http://dx.doi.org/10.1021/bi0490993
|
[11]
|
http://brf.jcs.anu.edu.au/services/Peptidesynthesis/spps.html
|
[12]
|
“Derivatives for Enhanced Peptide Synthesis,” Novabiochem 2004/2005 Catalog, pp 185-188.
|
[13]
|
E. K. Tiburu, P. C. Dave, J. F. Vanlerberghe, T. B. Cardon, R. E. Minto and G. A. Lorigan, “An Improved Synthetic and Purification Procedure for the Hydrophobic Segment of the Transmembrane Peptide Phospholamban,” Analytical Biochemistry, Vol. 318, 2003, pp. 146-151. http://dx.doi.org/10.1016/S0003-2697(03)00141-6
|